Tags

Type your tag names separated by a space and hit enter

[Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
Therapie. 1997 Mar-Apr; 52(2):97-103.T

Abstract

For several years, herbal medicines have been increasingly consumed by patients without prescription. They are traditionally innocuous but as medicinal products they require drug surveillance in order to identify their risks. However, the first concern is to give them a legal status, to evaluate their efficacy and to control their safety. Published data show that the risk is due either to a contaminant or to an added drug or falsification. Since 1985, the Regional Pharmacovigilance Centres have received about 341 reports of undesirable effects due to herbal medicines: among them 30 cases of hepatitis were reported associated with germander which has been now withdrawn from the French market. This example well illustrates the role of the national system and its responsibility for collecting and evaluating ADRs due to herbal medicines.

Authors+Show Affiliations

Centre Régional de Pharmacovigilance Hôpital Fernand Widal, Paris, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

fre

PubMed ID

9231502

Citation

Castot, A, et al. "[Pharmacovigilance Off the Beaten Track: Herbal Surveillance or Pharmacovigilance of Medicinal Plants]." Therapie, vol. 52, no. 2, 1997, pp. 97-103.
Castot A, Djezzar S, Deleau N, et al. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants]. Therapie. 1997;52(2):97-103.
Castot, A., Djezzar, S., Deleau, N., Guillot, B., & Efthymiou, M. L. (1997). [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants]. Therapie, 52(2), 97-103.
Castot A, et al. [Pharmacovigilance Off the Beaten Track: Herbal Surveillance or Pharmacovigilance of Medicinal Plants]. Therapie. 1997 Mar-Apr;52(2):97-103. PubMed PMID: 9231502.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants]. AU - Castot,A, AU - Djezzar,S, AU - Deleau,N, AU - Guillot,B, AU - Efthymiou,M L, PY - 1997/3/1/pubmed PY - 1997/3/1/medline PY - 1997/3/1/entrez SP - 97 EP - 103 JF - Therapie JO - Therapie VL - 52 IS - 2 N2 - For several years, herbal medicines have been increasingly consumed by patients without prescription. They are traditionally innocuous but as medicinal products they require drug surveillance in order to identify their risks. However, the first concern is to give them a legal status, to evaluate their efficacy and to control their safety. Published data show that the risk is due either to a contaminant or to an added drug or falsification. Since 1985, the Regional Pharmacovigilance Centres have received about 341 reports of undesirable effects due to herbal medicines: among them 30 cases of hepatitis were reported associated with germander which has been now withdrawn from the French market. This example well illustrates the role of the national system and its responsibility for collecting and evaluating ADRs due to herbal medicines. SN - 0040-5957 UR - https://www.unboundmedicine.com/medline/citation/9231502/[Pharmacovigilance_off_the_beaten_track:_herbal_surveillance_or_pharmacovigilance_of_medicinal_plants]_ L2 - https://medlineplus.gov/herbalmedicine.html DB - PRIME DP - Unbound Medicine ER -